Toronto, Ontario–(Newsfile Corp. – August 25, 2021) – PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) (“ PharmaDrug” or the “Company“), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs, is pleased to announce that the Company has entered into…

Source

Previous articleSilo Pharma Advances Psychedelic Patent Portfolio
Next articleClinical Director of Imperial College’s Center for Psychedelic Research Joins Entheon Advisory Board